Companies: 10,795·Total market cap: $144.5T
Dynavax Technologies Corporation

Dynavax Technologies Corporation

DVAXNASDAQHealthcare
$15.50
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio
52W High$15.73
52W Low$9.2

Dynavax Technologies Corporation(DVAX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DVAX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.28B$0.23B$0.72B$0.44B$0.05B
Cost of Revenue$0.05B$0.05B$0.26B$0.17B$0.01B
Gross Profit$0.23B$0.18B$0.46B$0.27B$0.03B
Gross Margin %(computed)82.17%78.40%63.73%60.50%70.12%
Operating Expenses
R&D Expenses$0.06B$0.05B$0.05B$0.03B$0.03B
G&A Expenses$0.17B$0.15B$0.13B$0.10B$0.08B
Total Operating Expenses$0.23B$0.22B$0.18B$0.13B$0.11B
Operating Income($0.00B)($0.04B)$0.28B$0.13B($0.08B)
Operating Margin %(computed)-1.49%-15.94%39.23%30.60%-161.59%
Interest Income$0.04B$0.03B$0.01B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.02B
Income Before Tax$0.03B($0.00B)$0.29B$0.08B($0.08B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income$0.03B($0.01B)$0.29B$0.08B($0.08B)
Net Margin %(computed)9.85%-2.75%40.56%17.46%-161.63%
Per Share & EBITDA
EPS (Basic)$0.21$-0.05$2.32$0.62$-0.75
Wtd Avg Shares0.13B0.13B0.13B0.12B0.10B
EBITDA$0.05B$0.01B$0.31B$0.10B($0.05B)
EBITDA Margin %(computed)16.48%4.16%42.58%21.79%-100.63%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Dynavax Technologies Corporation

关于Dynavax Technologies Corporation(DVAX)损益表

Dynavax Technologies Corporation(DVAX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,DVAX实现营收$0.28B,毛利润$0.23B(毛利率82.17%),净利润$0.03B(净利率9.85%)。

常见问题

DVAX · 4 问

Dynavax Technologies Corporation(DVAX)2024财年营收为$0.28B,同比up19.4%。

DVAX revenueDVAX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08